Plain-language brief
What this opportunity funds
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.
Eligibility at a glance
- Eligible applicants
- Public housing authorities/Indian housing authorities, Special district governments, State governments, For profit organizations other than small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification), Small businesses, Independent school districts, Native American tribal governments (Federally recognized), Public and State controlled institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, County governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, City or township governments
- Eligible locations
- Eligible applicants across the United States
- Eligible activities
- Health
- Matching requirement
- Not specified
- Registration
- SAM.gov, Grants.gov
Application process
- Read the complete official notice and confirm every eligibility rule.
- Complete required registrations early; federal registrations can take time.
- Build the budget, work plan, evidence, and attachments requested by the sponsor.
- Submit through the official portal and retain the confirmation.
Change history
No material changes have been recorded since this opportunity entered the hub.